安科生物: 监事会决议公告

Group 1 - The company held the 19th meeting of the 8th Supervisory Board on August 20, 2025, with all three attending supervisors voting unanimously to approve the half-year report and its summary [1][2] - The Supervisory Board confirmed that the procedures for preparing and reviewing the half-year report complied with legal and regulatory requirements, and the report accurately reflects the company's operational status without any false statements or omissions [1][2] Group 2 - The Supervisory Board approved a proposal to repurchase and cancel certain restricted stocks that do not meet incentive conditions from the third phase of the stock incentive plan [2] - The repurchase and cancellation will not affect the continuation of the third phase of the incentive plan, which will proceed according to regulatory requirements [2]